PubMed Health⌕ Search

Biomedical subjects

K A Smiles

Publications and source records attributed to K A Smiles.

6 recordsLinked to original sources
PubMed1990

Intralesional interferon alfa-2b for the treatment of genital warts.

A randomized, double-blind, placebo-controlled study has been conducted, and intralesional interferon alfa-2b was tested in the treatment of genital warts. This study design was to give 1 million units interferon alfa-2b intralesionally into the base of each of five external genital warts per patient, on a Monday-Wednesday-Friday treatment schedule for 3 weeks (total of nine injections). Forty-two patients were entered (20 randomized to receive interferon and 22 placebo injections). There were 43.8% of patients on the interferon treatment arm of the double-blind portion of the study who had complete disappearance of all warts, with an additional 25% of patients showing greater than 50% shrinkage of visible warts. On the placebo arm 14.3% showed a complete response, with an additional 14.3% showing greater than 50% shrinkage. This difference between interferon and placebo treatment was statistically significant (p less than 0.03). We conclude that intralesional interferon alfa-2b has significant activity in the treatment of genital warts.

Adolescent↗
PubMed1990

The effect of intralesional interferon gamma on basal cell carcinomas.

This open label study evaluated the effect of nine intralesional injections of two different doses of interferon gamma on basal cell carcinomas in 29 patients. One group of 15 patients received interferon gamma, 0.01 mg (20,000 IU), intralesionally three times a week for 3 weeks. Fourteen patients received interferon gamma, 0.05 mg (100,000 IU), intralesionally in the same dosage schedule. Excisional biopsy specimens 12 weeks after therapy showed no evidence of tumor remaining in 7 of 14 patients (50%) treated with the higher dose of interferon gamma, whereas only 1 of 15 patients (7%) treated with low-dose interferon gamma was cured according to histologic criteria (p = 0.025). Seventy-six percent of patients reported at least one adverse reaction, but most were considered mild by the patient and the investigator.

Adult↗
PubMed1976

Sweating responses during changes of hypothalamic temperature in the rhesus monkey.

A technique is presented for preparing a durable thermode implant in the hypothalamus of the rhesus monkey. In unanesthetized monkeys implanted with thermodes in the anterior hypothalamic area of the brain, a linear relation was found between local sweat rates on the general body surface and clamped hypothalamic temperature. Changes in skin temperature were found to shift the hypothalamic set-point temperature at which sweating began but did not alter the gain of the hypothalamic temperature-sweat rate relationship. This study provides direct support for the concept that central brain temperature and skin temperature interact additively in the control of sweating in higher primates. Due to the very close similarity between these responses and those seen with indirect measurements of brain temperature in men, the rhesus monkey is seen as an excellent experimental analogue for studying human thermoregulation.

Animals↗
PubMed1975

Effect of labyrinthectomy on the dynamic vestibulo-ocular counterrol reflex in the rhesus monkey.

Timeline records of eyeball counterrotation to constant speed rotations about the line of sight were examined in the Rhesus monkey via a linear transformer measurement system using a contact lens. Normal monkeys exhibited a decrease in the amplitude ratio of eye-to-chair motion and an increasing phase lag between eye and chair as the frequency of the motion platform increased. Bilateral labyrinthectomy or prolonged dosage with streptomycin was found to nearly abolish the counterroll reflex. Unilateral damage to the vestibular system resulted in a decrease in the amplitude ratio of the eye-to-chair motion by approximately 50% 1 month after surgery.

Aerospace Medicine↗